Mette Skov Holm

Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo

Petter Woll, Una Kjällquist, Onima Chowdhury et al. · Cancer Cell · 2014 · 320 citations · Full text

Medicine, Cell Biology, Oncology +14

Hypomethylation and up-regulation of<i>PD-1</i>in T cells by azacytidine in MDS/AML patients: A rationale for combined targeting of PD-1 and DNA methylation

Andreas Due Ørskov, Marianne Bach Treppendahl, Anni Skovbo et al. · Oncotarget · 2015 · 186 citations · Full text

Medicine, Molecular Biology, Oncology +17

Promoter hypermethylation of <i>p15</i>^{<i>INK</i>4<i>B</i>}, <i>HIC1</i>, <i>CDH1</i>, and <i>ER</i> is frequent in myelodysplastic syndrome and predicts poor prognosis in early‐stage patients

Anni Aggerholm, Mette Skov Holm, Per Guldberg et al. · European Journal Of Haematology · 2005 · 176 citations

Medicine, Molecular Biology, Molecular Genetics +17

Risk group assignment differs for children and adults 1–45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL‐2008 protocol

Nina Toft, Henrik Birgens, Jonas Abrahamsson et al. · European Journal Of Haematology · 2013 · 138 citations

Medicine, Oncology, Pediatrics +6

Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study

Reinhard Stauder, Ge Yu, Karin A. Koinig et al. · Leukemia · 2018 · 102 citations · Full text

Pharmacy, Hematology, Internal Medicine +17